van Staa TP - Search Results

1

The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?

van Staa TP, Smeeth L, Ng ES, Goldacre B, Gulliford M. van Staa TP, et al. Heart. 2013 Nov;99(21):1597-602. doi: 10.1136/heartjnl-2013-303698. Epub 2013 Jun 4. Heart. 2013. PMID: 23735939 Free PMC article.

2

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

Souverein PC, Berard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG, Walker BR. Souverein PC, et al. Among authors: van staa tp. Heart. 2004 Aug;90(8):859-65. doi: 10.1136/hrt.2003.020180. Heart. 2004. PMID: 15253953 Free PMC article.

3

What is the harm-benefit ratio of Cox-2 inhibitors?

van Staa TP, Smeeth L, Persson I, Parkinson J, Leufkens HG. van Staa TP, et al. Int J Epidemiol. 2008 Apr;37(2):405-13. doi: 10.1093/ije/dym296. Epub 2008 Feb 8. Int J Epidemiol. 2008. PMID: 18263647

4

Evaluating drug toxicity signals: is a hierarchical classification of evidence useful or a hindrance?

van Staa TP, Smeeth L, Persson I, Parkinson J, Leufkens HG. van Staa TP, et al. Pharmacoepidemiol Drug Saf. 2008 May;17(5):475-84. doi: 10.1002/pds.1568. Pharmacoepidemiol Drug Saf. 2008. PMID: 18322905

5

Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.

Rietbrock S, Heeley E, Plumb J, van Staa T. Rietbrock S, et al. Am Heart J. 2008 Jul;156(1):57-64. doi: 10.1016/j.ahj.2008.03.010. Am Heart J. 2008. PMID: 18585497

6

Changes in the characteristics of patients prescribed selective cyclooxygenase 2 inhibitors after the 2004 withdrawal of rofecoxib.

Setakis E, Leufkens HG, van Staa TP. Setakis E, et al. Among authors: van staa tp. Arthritis Rheum. 2008 Aug 15;59(8):1105-11. doi: 10.1002/art.23925. Arthritis Rheum. 2008. PMID: 18668614 Free article.

7

Selective decrease in consultations and antibiotic prescribing for acute respiratory tract infections in UK primary care up to 2006.

Gulliford M, Latinovic R, Charlton J, Little P, van Staa T, Ashworth M. Gulliford M, et al. J Public Health (Oxf). 2009 Dec;31(4):512-20. doi: 10.1093/pubmed/fdp081. Epub 2009 Sep 4. J Public Health (Oxf). 2009. PMID: 19734168 Free PMC article.

8

Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database.

Gulliford MC, Charlton J, Ashworth M, Rudd AG, Toschke AM; eCRT Research Team. Gulliford MC, et al. PLoS One. 2009 Sep 24;4(9):e7168. doi: 10.1371/journal.pone.0007168. PLoS One. 2009. PMID: 19777060 Free PMC article.

9

A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example.

van Staa TP, Leufkens HG, Zhang B, Smeeth L. van Staa TP, et al. PLoS Med. 2009 Dec;6(12):e1000194. doi: 10.1371/journal.pmed.1000194. Epub 2009 Dec 8. PLoS Med. 2009. PMID: 19997499 Free PMC article.

10

A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice.

Van Staa TP, Setakis E, Di Tanna GL, Lane DA, Lip GY. Van Staa TP, et al. J Thromb Haemost. 2011 Jan;9(1):39-48. doi: 10.1111/j.1538-7836.2010.04085.x. J Thromb Haemost. 2011. PMID: 21029359 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters